In a small clinical trial, customized mRNA vaccines against high-risk skin cancers appeared to reduce the risk of cancer recurrence and death by nearly 50 percent over five years when compared with ...

The only man in his immediate family to be without a cancer diagnosis, one Lynch syndrome patient made the trip to ...

Joe Ragey didn't think he would live to walk his daughter down the aisle, but thanks to Dr. Kelly Bolton at Washington ...

Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand ...

A Phase III clinical trial including patients at the University of Oklahoma found that proton therapy improved survival and resulted in fewer side effects among people with head and neck cancer. The ...

Could this mark a shift in how we think about cancer therapy? At least in the laboratory, evidence suggests it may be . An ...

A Tyler Trent Foundation donation is helping Diana Azzam’s lab grow its drug library and accelerate tumor testing that can ...

Johns Hopkins University cancer researcher Mikala Egeblad has received the 2025 Ernst W. Bertner Memorial Award in ...

Medical professionals in New York have partnered with a few others nationwide using new methods to study cancer treatments. The Cancer Research Institute said its “Discovery Engine” will help generate ...

Experts discuss the current status of neoadjuvant ADC therapies, eligibility criteria, and future treatment pathways for high-risk patients.

A team of Canadian scientists has uncovered a new way to slow the growth of glioblastoma, the most aggressive and currently ...